Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2022-09-16 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Outcome of committee meeting
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement addressed to stock exchanges (BSE and NSE) regarding the outcome of a Nomination and Remuneration Committee meeting. It reports the issuance and allotment of equity shares upon conversion of stock options under an ESOP scheme. The document is brief (1319 characters) and serves as an official notification of a committee decision related to share issuance. It does not contain detailed financial statements or comprehensive report content. Therefore, it is best classified as a Share Issue/Capital Change announcement (SHA).
2022-09-16 English
Bodal Chemicals Limited has informed the Exchange about issuance of Duplicate share certificate
Regulatory Filings
2022-09-16 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document text is extremely short (216 characters) and contains no substantive content other than references to omitted pictures and a digital signature. There is no financial data, report content, or detailed information. This suggests it is not a full report but likely a certification or a very brief filing. Given the lack of any report content and the presence of a digital signature, it is most consistent with a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings without substantive report data.
2022-09-16 English
Bodal Chemicals Ltd hereby submit reply letter in regard to the clarification sought by Exchnage
Regulatory Filings
2022-09-13 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on unusual price and volume movements of the company's stock. It explicitly states that there is no undisclosed information affecting the stock price and confirms compliance with SEBI listing regulations. The document is short (1453 characters) and serves as a regulatory communication or clarification rather than a financial report or announcement of results. It does not contain financial data, management changes, voting results, or any other reportable event categories. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2022-09-13 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges of upcoming investor interactions by company executives. There is no financial data, report, or detailed presentation included, only an announcement of meetings. This fits the category of Investor Presentation announcements or updates. However, since it is only an intimation of the schedule of meetings and not the presentation itself, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement. The document length is short (1501 characters), and it is an announcement rather than a report or transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-09-12 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.